Friday, April, 19, 2019 05:22:41

Category: Health

Glenmark Pharma ventures into the U.S. branded dermatology sector

Glenmark’s branded portfolio will be developed and commercialized under the subsidiary Glenmark Therapeutics Inc., USA. Renowned pharmaceutical firm, Glenmark Pharmaceuticals has recently announced that its wholly owned subsidiary, Glenmark Therapeutics Inc., USA, will enter the branded dermatology segment in the United States. This will be …

Staten & Novo Nordisk partner to develop dyslipidaemia treatment

Forbion, a healthcare venture capital firm with centers in Germany and the Netherlands, recently announced that its portfolio company Staten Biotechnology B.V. and Denmark-based healthcare company Novo Nordisk A/S have collaborated and signed an exclusive option agreement in a bid to develop new therapeutics hypertriglyceridaemia …

BiomX collaborates with J&J Innovation to develop biomarker platform

The collaboration will focus on developing biomarkers to detect diseases like cancer, liver disease, and IBD. Renowned microbiome drug developing firm, BiomX Ltd. has recently announced a collaboration with Johnson & Johnson’s Janssen Research & Development, LLC to exploit its microbiome-based biomarker discovery platform, XMarker. …